UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 117

Sortiert nach

Translating gammadelta (γδ) T cells and their receptors into cancer cell therapies

Nature reviews. Drug discovery, 2020-03, Vol.19 (3), p.169-184

2020

Volltextzugriff (PDF)

Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma

Haematologica (Roma), 2016-05, Vol.101 (5), p.616

2016

Volltextzugriff (PDF)

RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell Receptor

Cell reports (Cambridge), 2016-05, Vol.15 (9), p.1973-1985

2016

Volltextzugriff (PDF)

Serpin B9 controls tumor cell killing by CAR T cells

Journal for immunotherapy of cancer, 2023-03, Vol.11 (3), p.e006364

2023

Volltextzugriff (PDF)

Cellular immunotherapy on primary multiple myeloma expanded in a 3D bone marrow niche model

Oncoimmunology, 2018-06, Vol.7 (6), p.e1434465-e1434465

2018

Volltextzugriff (PDF)

Gamma delta TCR anti-CD3 bispecific molecules (GABs) as novel immunotherapeutic compounds

Journal for immunotherapy of cancer, 2021-11, Vol.9 (11), p.e003850

2021

Volltextzugriff (PDF)

BEHAV3D: a 3D live imaging platform for comprehensive analysis of engineered T cell behavior and tumor response

Nature protocols, 2024-07, Vol.19 (7), p.2052-2084

2024

Volltextzugriff (PDF)

The Role of γδ T Cells as a Line of Defense in Viral Infections after Allogeneic Stem Cell Transplantation: Opportunities and Challenges

Viruses, 2022-01, Vol.14 (1), p.117

2022

Volltextzugriff (PDF)

γ9δ2 T-Cell Expansion and Phenotypic Profile Are Reflected in the CDR3δ Repertoire of Healthy Adults

Frontiers in immunology, 2022-07, Vol.13, p.915366-915366

2022

Volltextzugriff (PDF)

Evaluating in vivo efficacy - toxicity profile of TEG001 in humanized mice xenografts against primary human AML disease and healthy hematopoietic cells

Journal for immunotherapy of cancer, 2019-03, Vol.7 (1), p.69-69, Article 69

2019

Volltextzugriff (PDF)

IMAT-IGRT Treatment with Simultaneous Integrated Boost as Dose Escalation for Patients with Cervical Cancer: A Single Institution, Prospective Pilot Study

Pathology oncology research, 2021-03, Vol.27, p.608446-608446

2021

Volltextzugriff (PDF)

Adding Help to an HLA-A24:02 Tumor-Reactive γδTCR Increases Tumor Control

Frontiers in immunology, 2021-10, Vol.12, p.752699-752699

2021

Volltextzugriff (PDF)

A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells

Oncoimmunology, 2018-01, Vol.7 (1), p.e1375641-e1375641

2018

Volltextzugriff (PDF)

TCRs genetically linked to CD28 and CD3ε do not mispair with endogenous TCR chains and mediate enhanced T cell persistence and anti-melanoma activity

The Journal of immunology (1950), 2014-11, Vol.193 (10), p.5315-5326

2014

Volltextzugriff (PDF)

Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AML

Journal for immunotherapy of cancer, 2024-04, Vol.12 (4), p.e008174

2024

Volltextzugriff (PDF)

Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1

Journal for immunotherapy of cancer, 2024-03, Vol.12 (3), p.e007538

2024

Volltextzugriff (PDF)

Assessment of the results and hematological side effects of 3D conformal and IMRT/ARC therapies delivered during craniospinal irradiation of childhood tumors with a follow-up period of five years

BMC cancer, 2020-07, Vol.20 (1), p.702-7, Article 702

2020

Volltextzugriff (PDF)

T cell receptor gene therapy: strategies for optimizing transgenic TCR pairing

Trends in molecular medicine, 2010-02, Vol.16 (2), p.77-87

2010

Volltextzugriff (PDF)

T‐cell synapse formation depends on antigen recognition but not CD3 interaction: Studies with TCR:ζ, a candidate transgene for TCR gene therapy

European journal of immunology, 2011-05, Vol.41 (5), p.1288-1297

2011

Volltextzugriff (PDF)

Cover Picture: Eur. J. Immunol. 5/11

European journal of immunology, 2011-05, Vol.41 (5), p.np-n/a

2011

Volltextzugriff (PDF)

Lipid rafts and the local density of ErbB proteins influence the biological role of homo- and heteroassociations of ErbB2

Journal of cell science, 2002-11, Vol.115 (Pt 22), p.4251-4262

2002

Volltextzugriff (PDF)

TCR‐engineered T cells: A model of inducible TCR expression to dissect the interrelationship between two TCRs

European journal of immunology, 2014-01, Vol.44 (1), p.265-274

2014

Volltextzugriff (PDF)

GMP-Grade Manufacturing of T Cells Engineered to Express a Defined γδTCR

Frontiers in immunology, 2018-05, Vol.9, p.1062-1062

2018

Volltextzugriff (PDF)

Stereotactic radiosurgery of abdominal cancer metastases. Report on the first successful extracranial radiosurgical intervention in Hungary

Orvosi hetilap, 2015-09, Vol.156 (39), p.1593

2015

Volltextzugriff (PDF)

1 – 25 von 117

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(109)
Mit Volltextzugriff
(100)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Translating gammadelta (γδ) T cells and their receptors into cancer cell therapies

Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma

RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell Receptor

Serpin B9 controls tumor cell killing by CAR T cells

Cellular immunotherapy on primary multiple myeloma expanded in a 3D bone marrow niche model

Dual targeting of cancer metabolome and stress antigens affects transcriptomic heterogeneity and efficacy of engineered T cells

Gamma delta TCR anti-CD3 bispecific molecules (GABs) as novel immunotherapeutic compounds

BEHAV3D: a 3D live imaging platform for comprehensive analysis of engineered T cell behavior and tumor response

The Role of γδ T Cells as a Line of Defense in Viral Infections after Allogeneic Stem Cell Transplantation: Opportunities and Challenges

γ9δ2 T-Cell Expansion and Phenotypic Profile Are Reflected in the CDR3δ Repertoire of Healthy Adults

Evaluating in vivo efficacy - toxicity profile of TEG001 in humanized mice xenografts against primary human AML disease and healthy hematopoietic cells

IMAT-IGRT Treatment with Simultaneous Integrated Boost as Dose Escalation for Patients with Cervical Cancer: A Single Institution, Prospective Pilot Study

Adding Help to an HLA-A24:02 Tumor-Reactive γδTCR Increases Tumor Control

A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells

TCRs genetically linked to CD28 and CD3ε do not mispair with endogenous TCR chains and mediate enhanced T cell persistence and anti-melanoma activity

Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AML

Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1

Assessment of the results and hematological side effects of 3D conformal and IMRT/ARC therapies delivered during craniospinal irradiation of childhood tumors with a follow-up period of five years

T cell receptor gene therapy: strategies for optimizing transgenic TCR pairing

T‐cell synapse formation depends on antigen recognition but not CD3 interaction: Studies with TCR:ζ, a candidate transgene for TCR gene therapy

Cover Picture: Eur. J. Immunol. 5/11

Lipid rafts and the local density of ErbB proteins influence the biological role of homo- and heteroassociations of ErbB2

TCR‐engineered T cells: A model of inducible TCR expression to dissect the interrelationship between two TCRs

GMP-Grade Manufacturing of T Cells Engineered to Express a Defined γδTCR

Stereotactic radiosurgery of abdominal cancer metastases. Report on the first successful extracranial radiosurgical intervention in Hungary

Suchergebnisse filtern